Observatory: Herpes Infected ‘Since Before We Were Human’
New research says that both oral and genital herpes have been infecting humans and our ancestors for longer than previously thought. (Source: NYT Health)
Source: NYT Health - June 23, 2014 Category: Consumer Health News Authors: By DOUGLAS QUENQUA Tags: Herpes Viruses Source Type: news
Current Thinking on Genital HerpesCurrent Thinking on Genital Herpes
Recent advances in our understanding of genital herpes may help guide new strategies for disease prevention and control. Current Opinion in Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 25, 2014 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news
Kenya: Herpes Infection Cannot Be Prevented By Use of Condom
[The Star]Did you know that genital herpes is the most common sexually transmitted infection? Gynaecologist John Ong'ech adds that it cannot be prevented by using a condom. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - February 20, 2014 Category: Infectious Diseases Source Type: news
Genital Herpes: When Can I Stop Taking Acyclovir? polyDNA Answers...
In its latest December, 2013 survey, polyDNA found that up to 82% of respondents wanted to know when they could stop taking Acyclovir against their herpes infection. polyDNA reviews the literature on...(PRWeb January 27, 2014)Read the full story at http://www.prweb.com/releases/2014/01/prweb11515762.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 27, 2014 Category: Pharmaceuticals Source Type: news
Pritelivir May Be Effective and Safe Against Genital HerpesPritelivir May Be Effective and Safe Against Genital Herpes
In a proof-of-concept study, researchers have found pritelivir to be safe and effective against genital herpes simplex virus. Medscape Medical News (Source: Medscape ObGyn and Womens Health Headlines)
Source: Medscape ObGyn and Womens Health Headlines - January 16, 2014 Category: OBGYN Tags: Infectious Diseases News Source Type: news
Investigational Herpes Drug Limits Viral Shedding in Phase II Trial (FREE)
By Kelly Young
Pritelivir, the first in a new class of drugs (a helicase-primase inhibitor) for herpes simplex virus, effectively suppressed viral shedding and development of genital lesions in an industry-conducted, phase II … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 16, 2014 Category: Primary Care Source Type: news
New Herpes Drug Blocks Viral Shedding (CME/CE)
(MedPage Today) -- An investigational drug with a novel mechanism of action reduced the rate of viral shedding in patients with genital herpes simplex-2 (HSV-2) infection, researchers reported. (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - January 16, 2014 Category: Infectious Diseases Source Type: news
Experimental Drug Shows Promise for Genital Herpes Treatment
But larger, longer trials are needed, experts say (Source: Fertility News - Doctors Lounge)
Source: Fertility News - Doctors Lounge - January 15, 2014 Category: Reproduction Medicine Authors: webmaster at doctorslounge.com Tags: Pharmacy, Reproductive Medicine, Research, News, Source Type: news
Singles with Herpes Can Have An Active Social Life
Rather than struggling with feelings of alienation, or having any anxiety about dating once diagnosed as having genital herpes, life can be lived to its fullest by socializing and dating within a...(PRWeb December 04, 2013)Read the full story at http://www.prweb.com/releases/2013/12/prweb11381680.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 4, 2013 Category: Pharmaceuticals Source Type: news
Study: Cold Sores High Risk for Genital Herpes; polyDNA Recommends...
An article published on Drugs.com on October 17 said that today's teens may be at higher risk than ever of contracting genital herpes because fewer numbers are being exposed as children to HSV-1...(PRWeb November 13, 2013)Read the full story at http://www.prweb.com/releases/2013/11/prweb11320619.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 14, 2013 Category: Pharmaceuticals Source Type: news
LocalHerpesDating.org Publishes the Steps on How to Date with Genital...
The first date after a genital herpes diagnosis may seem a little strange, however. If you hope to be sexually intimate with your date at some point, you may feel like you're keeping a secret....(PRWeb November 13, 2013)Read the full story at http://www.prweb.com/releases/2013/11/prweb11320119.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 14, 2013 Category: Pharmaceuticals Source Type: news
Clinical trial begun of a vaccine to prevent genital herpes
BETHESDA, Md., Nov. 8 (UPI) -- U.S. researchers began an early stage clinical trial of a vaccine to prevent genital herpes disease by removing two key proteins so the virus cannot multiply. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 9, 2013 Category: Consumer Health News Source Type: news
NIH launches trial of investigational genital herpes vaccine
Treatment designed to prevent one of the most common sexually transmitted infections in the United States. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - November 8, 2013 Category: American Health Source Type: news
Genital Herpes Vaccine Succeeds in Mid-Stage TrialGenital Herpes Vaccine Succeeds in Mid-Stage Trial
Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 8, 2013 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
NIH launches trial of investigational genital herpes vaccine
(NIH/National Institute of Allergy and Infectious Diseases) Researchers have launched an early-stage clinical trial of an investigational vaccine designed to prevent genital herpes disease. The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, is sponsoring the Phase I trial, which is being conducted at the NIH Clinical Center in Bethesda, Md. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 8, 2013 Category: Global & Universal Source Type: news
